Publicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (2)

2023

  1. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

    Cell Reports Medicine, Vol. 4, Núm. 12

2020

  1. Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations

    Journal of Clinical Immunology, Vol. 40, Núm. 7, pp. 987-1000